Can intrarenal duplex waveform analysis predict successful renal artery revascularizaion?  by Cohn, E.Jerry et al.
Can intrarenal duplex waveform analysis
predict successful renal artery
revascularizaion?
E. Jerry Cohn, Jr, MD, Marshall E. Benjamin, MD, Gail P. Sandager, RN,
RVT, Michael P. Lilly, MD, Lois A. Killewich, MD, PhD, and William R.
Flinn, MD, Baltimore, Md
Purpose: No currently available noninvasive test can preoperatively predict a successful
outcome to renal revascularization. Resistance measurements from the renal parenchyma
obtained with duplex sonography reflect the magnitude of intraparenchymal disease,
and patients with extensive intrarenal disease may respond less favorably to revascular-
ization. To address this question, we reviewed our (primarily) operative experience in
patients undergoing renal artery revascularization, and compared the blood pressure
(BP) and renal function response with resistance measurements obtained from the kid-
ney both before and after revascularization. 
Methods: During a 56-month period, 31 consecutive renal artery revascularizations (25
surgical and 6 percutaneous angioplasties) were performed in 23 patients (21 athero-
sclerotic, 2 fibromuscular dysplasia). Duplex sonography was performed in each patient
before and after revascularization, and parenchymal diastolic/systolic (d/s) ratios were
calculated. BP and renal function response to intervention were compared with mea-
surements of intrarenal flow patterns before and after revascularization.
Results: Mean parenchymal peak systolic velocity was significantly higher after repair in
all patients (pre-repair: 19.5 ± 1.3, postrepair: 27.2 ± 1.7; P < .0001). Despite this, there
were no statistical differences between preoperative and postoperative parenchymal d/s
ratios. A favorable (cured or improved) BP response was seen in 81% (17 of 21) of revas-
cularizations performed for hypertension. Among these successes, parenchymal d/s
ratios were in the normal range (ie, ‡ 0.30) both before and after repair (mean pre-
repair: 0.34 ± 0.03, mean postrepair: 0.31 ± 0.03; not significant). In 4 patients in
which BP failed to improve after intervention, the d/s ratio was abnormal before
surgery (<0.3), and remained so after revascularization (mean preoperative d/s ratio:
0.18 ± 0.04, mean postoperative d/s ratio: 0.11 ± 0.04; P = .003). Mean preoperative
parenchymal d/s ratios were significantly higher in all patients with a successful BP
response when compared with failures (P = .048). Similarly, among patients with single
artery repairs, mean preoperative d/s ratios approached significance in successes vs. failures
(success: 0.40 ± 0.03, failure: 0.21 ± 0.03; P = .054). A decrease in serum creatinine
greater than or equal to 20% was seen in 8 of 18 patients (44%) with ischemic nephropa-
thy. These patients also had normal d/s ratios preoperatively (mean 0.39 ± 0.04), where-
as the 10 patients who failed to improve had significantly lower ratios (mean 0.24 ± 0.03;
P = .041). Kidney length did not correlate with d/s ratio.
Conclusion: Although we do not believe that duplex sonographic measurement of
intrarenal flow patterns alone is an accurate means of assessing main renal artery occlu-
sive disease, the resistive indices seem to reflect the magnitude of intraparenchymal disease,
and thus may provide important prognostic information for patients undergoing surgical
revascularization. Our data suggest that a preoperative d/s ratio below 0.3 correlates with
clinical failure relative to BP and renal function responses. (J Vasc Surg 1998;28:471-81.)
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INTRODUCTION
Renal artery revascularization is a well-accepted
form of treatment for patients with significant occlu-
sive disease resulting in renovascular hypertension,
ischemic nephropathy, or both. Numerous contem-
porary studies have demonstrated the benefits of
renal revascularization, but despite these recognized
contributions, a heterogeneous response is often
seen after revascularization, illustrating the inade-
quacies of the currently available preoperative “pre-
dictors” of intervention on the renal artery.1–5 There
are no currently available, universally accepted, non-
invasive tests capable of accurately predicting preop-
eratively which patients will have a beneficial
response to revascularization of an ischemic kidney. 
Renal artery duplex sonography has, in the past
20 years, proven its reliability in the evaluation of
patients with main renal artery disease and in the
assessment after intervention (surgical revasculariza-
tion or angioplasty). Although numerous studies
have documented the accuracy of the main renal
artery examination, the results of renal hilar or
parenchymal scanning alone in the evaluation of
main renal artery occlusive lesions remains contro-
versial.6,7 However, from these parenchymal studies
information reflecting elevated intrarenal vascular
resistance can be reliably obtained and may yield
information and insight into why some interventions
are successful, whereas others result in therapeutic
failure.
Although stenoses of the main renal artery are
accurately identified by means of duplex ultrasound,
a more distal intrarenal evaluation of the interlobar,
arcuate, and interlobular arteries reflects the
intrarenal vascular resistance. One such duplex mea-
surement of intrarenal vascular resistance is the end-
diastolic to peak-systolic (d/s) velocity ratio,
obtained from within the parenchyma of the kidney.
Although previous investigators have associated ele-
vated intrarenal resistance measurements in
extrarenal conditions (for example, acute postrenal
obstruction8–10), elevated intrarenal resistance is also
known to occur in kidneys of patients with severe
parenchymal vascular disease.11–14 A group at the
University of Washington has shown that this is
associated with a low d/s ratio and may be associat-
ed with therapeutic failure after revascularization.15
They further demonstrated that, in general, there
was little variability of the d/s ratio in normal or
minimally diseased kidneys. Thus, it appears that the
measurement of d/s ratios is very reproducible.
Using this easily obtainable duplex sonographic
measurement (d/s ratio) preoperatively to predict a
successful intervention on the renal artery has obvi-
ous advantages. Renal revascularization in itself car-
ries measurable risks to the patient, and if a patient
with little potential for benefit from renal revascular-
ization could be identified before intervention, then
those associated risks might be avoided. Prior stud-
ies have shown that elevated intrarenal vascular resis-
tance (low d/s ratio) obtained before renal revascu-
larization is suggestive of a poor outcome to inter-
vention.15 Furthermore, disease states, such as
diabetes mellitus, were once even considered a rela-
tive contraindication to revascularization because of
the frequent occurrence of significant intrarenal
parenchymal disease (eg, diabetic nephropathy).16,17
To date, the only study that has used d/s ratio to
predict a successful outcome, has come from
patients undergoing primarily percutaneous angio-
plasty (PTA) of the renal arteries.15 Could intrarenal
resistance measurements obtained preoperatively,
from within the kidney hilum and renal parenchyma,
be used to predict the response to surgical revascu-
larization? To address this question, we made a ret-
rospective review of our (primarily) operative experi-
ence with consecutive patients undergoing renal
artery revascularization at our center, and compared
the BP and renal function response with interven-
tion with the d/s ratios obtained both before and
after revascularization. 
MATERIAL AND METHODS
From March 1994 to November 1997, 23
patients underwent 31 interventions for renal artery
occlusive disease at the University of Maryland
Medical Center. The demographics of this patient
group are listed in Table I. Twenty-one (91%)
patients had atherosclerotic renal artery disease, and
2 were treated for fibromuscular dysplasia (FMD).
Some degree of preoperative renal dysfunction
(serum creatinine levels of ‡ 1.3 mg/dL) was seen in
18 of the 23 patients (78%), and 3 patients required
dialysis before intervention.
Technique of revascularization
Of the 23 patients who underwent renal revas-
cularization, 7 had treatment of both renal arteries,
6 had surgical revascularization, and 1 had bilateral
PTA. Repair of a single renal artery was performed
in 16 patients, including 4 patients who had revas-
cularization of a solitary kidney. Operative recon-
struction was performed in 13 of the single renal
artery cases, including all who had revascularization
of a solitary kidney. Four patients treated for disease
of a single renal artery had PTA alone or with stent
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placement. One patient in this latter group had sur-
gical revascularization for late recurrence of hyper-
tension after an initially successful PTA. The 2 pro-
cedures in this patient were treated as separate
events for the purposes of data analysis. 
Overall, surgical revascularization of 25 kidneys
was performed during this study. Table I lists the
details of these procedures. Renal artery bypass was
performed in 16 cases (64%). In 6 cases, bypass was
performed with an ePTFE graft, and in 10 cases, a
saphenous vein graft was used. Thirteen patients in
the study group (68% of patients having surgical
repair) underwent concomitant aortic reconstruction.
Renal Duplex Ultrasound Scanning 
All patients underwent complete renal artery
color-flow duplex sonography (RDS) before and
after each intervention, with a commercially available
scanner (HDI Ultramark-9, Advanced Technology
Laboratories, Bethell, WA). Kidney length was mea-
sured along the long axis of each kidney. The renal
arteries were approached transabdominally and/or
from a flank approach and were interrogated from
their origin to the renal hilum. A focal increase in
peak systolic velocity (PSV) more than 2 meters/s
associated with poststenotic turbulence or a
renal/aortic ratio of PSV greater than or equal to 3.5
were considered to be diagnostic of a diameter renal
artery stenosis greater than or equal to 60%.18-20
Renal parenchymal Doppler signals were
acquired with the patient in a lateral decubitus posi-
tion, rotating the scan head to obtain the greatest
longitudinal image of the kidney. A zero-degree
Doppler angle was assumed, and a large sample vol-
ume (>10 mm) was used to record pulsed-Doppler
spectral waveforms from the renal parenchyma of
each kidney.21 For consistency, every attempt was
made to position the sample volume at the corti-
comedullary junction. The d/s ratio was calculated
by dividing the end diastolic velocity by the peak sys-
tolic velocity measured from the parenchymal wave-
forms (Fig. 1). Three representative spectral samples
were obtained from the upper and lower poles of
each kidney, and the final d/s ratios reported for a
kidney was the mean value from the upper and lower
poles. Fig. 2 demonstrates examples of characteristic
parenchymal spectral waveforms.
Technical and clinical success
A renal revascularization procedure was initially
defined as technically successful by means of the
findings on the post-procedure duplex scan. Graft or
renal artery patency was determined in surgically
treated cases by direct RDS examination of the ves-
sel or bypass conduit. Hemodynamic success of PTA
procedures was determined using the same RDS
diagnostic criteria as the preoperative examination. 
Clinical success was determined by either the BP
response or changes in the patient’s renal function,
according to published criteria that have been
described previously.22,23 The definitions are sum-
marized below. BP control and antihypertensive
medication requirements observed at least 8 weeks
after repair (or until death) were used to define
patients’ BP response to revascularization. Cure or
significant clinical improvement in BP control was
defined as a successful BP response. A cure was
JOURNAL OF VASCULAR SURGERY
Volume 28, Number 3 Cohn et al 473
Fig. 1. Diagram shows how the diastolic/systolic ratio for
each arterial waveform was calculated from the ratio of the
end-diastolic velocity (EDV) to the peak systolic velocity
(PSV).
Table I. Patient demographics and type of repairs
performed (N = 23 Patients and 31 Repairs)
ASCD FMD
Demographics
Male 10/21 0/2
Caucasian 15/21 2/2
Mean age 68.5 ± 1.6* 45.7 ± 2.9
Preoperative hypertension 19/21 (90%) 2/2 (100%)
Preoperative coronary disease 11/21 (52%) 0/2
Preoperative diabetes mellitus 2/21 (10%) 0/2
Preoperative congestive heart 10/21 (48%) 0/2
failure
Repair type
Unilateral PTA 2 2
Bilateral PTA/stent 2
Contralateral nephrectomy 2
Renal endarterectomy 3
Reimplantation 6
Aortorenal RSVG 9
Aortorenal PTFE 6
Ex vivo 1
ASCD, atherosclerotic disease; FMD, fibromuscular dysplasia as
etiology of renal artery stenosis.
* = Mean (± SE) age of patients with atherosclerosis significantly
older than patients with fibromuscular dysplasia (P = .018).
defined as a diastolic BP of 90 mm Hg or less with
no antihypertensive therapy. Patients were consid-
ered clinically improved if they met the following
criteria: (1) medication requirements to achieve con-
trol were reduced by at least 2 drugs; (2) a decrease
in diastolic BP that was less than 20 mm Hg, but
medication requirements were reduced by at least 1
drug; and (3) a decrease in diastolic pressure of 20
mm Hg or more, on the same medications as before
treatment. Patients not meeting these criteria for
cure or improvement were classified as having a
failed BP response to revascularization. A successful
renal functional response to intervention was deter-
mined by a decrease in serum creatinine after revas-
cularization greater than or equal to 20%. Patients
with a decrease in serum creatinine less than 20% or
worsening renal function after intervention were
defined as having functional failures.
Analysis of blood pressure and functional
outcome
Mean parenchymal d/s ratios in the groups of
patients determined to have successful BP or renal
functional outcome as defined above were compared
JOURNAL OF VASCULAR SURGERY
474 Cohn et al September 1998
Fig. 2. A, Normal (low resistance) Doppler spectral waveform obtained from the renal parenchyma.
Note that the end-diastolic velocity is relatively high in comparison with the peak systolic velocity, and
the diastolic/systolic ratio is normal at 0.52. B, Abnormal (high resistance) Doppler spectral waveform.
The end-diastolic velocity is relatively low, with a diastolic/systolic ratio of 0.23.
with mean d/s ratios in patient groups that had
unsuccessful outcomes. In cases in which bilateral
repairs were performed, the lowest pre-repair d/s
ratio from the treated kidneys was chosen to repre-
sent the patient’s preoperative value. This assumed
that the kidney with the highest measure of
parenchymal resistance (lowest d/s ratio) represent-
ed the side at highest risk for a clinical failure.
Statistical comparisons of the mean values for differ-
ent groups were performed using the Student’s t-
test. Categorical variables were analyzed using
Fisher’s Exact test. A P-value of .05 was considered
to represent statistically significant differences. 
RESULTS
Parenchymal d/s Ratios
Twenty-three patients underwent 31 interven-
tions for renal artery stenosis. The mean pre-proce-
dural d/s ratio for all patients was 0.34 ± 0.03,
which did not differ significantly from the mean
post-treatment d/s ratio (0.31 ± 0.03, P = .385). In
21 patients whose renal artery disease was caused by
atherosclerosis, the mean d/s ratio was 0.33 ± 0.03
before treatment and did not change significantly
after treatment (post-treatment: 0.30 ± 0.03, P =
.553). Patients undergoing bilateral repair had no
difference in pre-repair or post-repair d/s ratios of
either kidney (left kidney pre-repair d/s ratio = 0.30
± 0.04, right kidney pre-repair d/s ratio = 0.29 ±
0.06, P = .9571; post-repair d/s ratios = 0.34 ± 0.06
and 0.28 ± 0.04, P = .292). Patients undergoing
operative repair were observed to have no difference
between preoperative and postoperative parenchymal
d/s ratios (preoperative: 0.34 ± 0.02, postoperative:
0.30 ± 0.03, P = .227), and the findings were similar
in 6 patients who had PTA (pre-PTA: 0.31 ± 0.07,
post-PTA: 0.34 ± 0.04, P = .701). Two patients
treated for FMD had slightly higher d/s ratios than
the patients with atherosclerosis (pre: 0.49 ± 0.08),
but this difference was not significant (P = .368).
Technical success
Revascularization procedures were patent and
hemodynamically successful in 29 of the 31 treated
kidneys (93.5%). There was a significant increase in
the pulsed Doppler-derived mean parenchymal PSV
in kidneys with successful revascularization from
19.5 cm/s to 27.2 cm/s after treatment (P <
.0001). 
Two patients were found to have early graft
occlusion at the time of postoperative RDS (both
vein bypasses for atherosclerosis). Both were found
to have low parenchymal PSVs, unchanged from
preoperative levels. Both these patients had preoper-
ative d/s ratios less than 0.3. 
Blood pressure response
Twenty-one patients underwent renal revascular-
ization for hypertension, and a successful BP
response was observed in 17 cases (81%). Patients
with a favorable BP response had a significantly high-
er mean pre-repair d/s ratio than 4 patients with an
unfavorable response (0.37 ± 0.03 in successes, 0.18
± 0.04 in failures; P = .048). Fourteen of the 17
patients with successful BP response had a d/s ratio
greater than or equal to 0.3, whereas the 4 cases with
unsuccessful BP responses all had a d/s ratio less than
0.3. This is depicted graphically in Fig. 3, A. Thus,
patients with a d/s ratio greater than or equal to 0.3
before treatment were significantly more likely to
have a successful BP response (P = .006). 
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Fig. 3. A, Scatter plot of preoperative parenchymal dias-
tolic/systolic ratios of the patients with successful and
unsuccessful blood pressure response to intervention.
(Error bars indicate the standard error of the mean.) B,
Scatter plot of preoperative parenchymal diastolic/systolic
ratios of the patients with successful and unsuccessful
function response to intervention. (Error bars indicate the
standard error of the mean.)
Atherosclerosis was the cause of the renal artery
lesion in 18 patients with hypertension, and 14 of
the 18 patients (77%) had improvement in BP con-
trol after repair. Mean pre-repair d/s ratio was sig-
nificantly higher in patients who had improvement,
as compared with the 4 patients with atherosclerotic
lesions who failed to achieve improvement in BP
control (success: 0.35 ± 0.02, failure: 0.18 ± 0.04, P
= .048). Atherosclerotic patients who had a favor-
able BP result (11 of 14, 78.6%) were significantly
more likely to have a d/s ratio greater than or equal
to 0.3, as compared with those with an unfavorable
result (0 of 4, P = .023).
Repair of a single renal artery was performed for
hypertension in 14 cases, and 11 patients had
improvement in BP. Higher pretreatment d/s ratios
were observed in these 11 than in the 3 patients with
clinical failure after single artery repair (mean suc-
cess: 0.40 ± 0.03, mean failure: 0.21 ± 0.03, P =
.054). Eight of 11 patients with atherosclerosis
undergoing single artery repair for hypertension had
improvements in BP. Pre-repair d/s ratios in this
subgroup also approached, but was not significantly
higher than, single artery failures (mean success:
0.37 ± 0.03, mean failure: 0.21 ± 0.03, P = .054).
Table II lists mean systolic and diastolic BP in all
patients before and after repair.
Renal functional response
Eighteen patients with preoperative renal insuffi-
ciency underwent bilateral (N = 6) or single artery
repair (N = 12) of renal artery stenosis. Eight
patients (44%) had a decrease in serum creatinine
greater than or equal to 20% after treatment, and
these cases were considered functional successes.
Pre-repair d/s ratios were significantly higher in the
patients that achieved functional improvement, as
compared with the group of patients with no func-
tional improvement (success: 0.39 ± 0.04, failure:
0.24 ± 0.03, P = .041). Twelve patients with single
artery repairs had renal insufficiency preoperatively.
Mean pre-repair d/s ratio of 6 patients with a func-
tional improvement was 0.39 ± 0.05, vs. 0.25 ± 0.03
in 6 patients with no improvement in serum creati-
nine levels (P = .078). Fig. 3, B depicts individual
pre-repair parenchymal d/s ratio in all functional
successes and failures.
Comparisons between patients undergoing
either bilateral or solitary renal artery repairs (ie, the
whole renal mass) and patients undergoing unilater-
al repairs revealed no significant difference between
pre-repair d/s ratios in either group (pre-repair
bilateral/solitary = 0.30 ± 0.04, pre-repair unilater-
al = 0.32 ± 0.04, P = .8156). Four of 10 patients
with bilateral or solitary repair had functional
improvement, and the pre-repair d/s ratio was sig-
nificantly higher than in 6 patients with functional
failure (successful bilateral/solitary = 0.38 ± 0.06,
failed bilateral/solitary = 0.25 ± 0.05, P = .0285).
Four of 8 patients undergoing unilateral repair had a
functional improvement. Pre-repair d/s ratios in
unilateral repairs with functional improvement were
higher than unilateral functional failures, but
this was not significantly different (successful unilat-
eral = 0.40 ± 0.04, failed unilateral = 0.23 ± 0.03,
P = .0798). Pre-repair d/s ratios were not signifi-
cantly higher between bilateral/solitary repairs and
unilateral repairs in successes or failures (P = .7485
in successes, P = .955 in failures).
Two of the 3 patients on dialysis before renal
revascularization were functionally improved after
treatment. Both patients had renal artery bypass.
One patient had a reduction in the frequency of dial-
ysis treatments, and the other no longer needed dial-
ysis. The third dialysis patient in this study had no
functional improvement after PTA of a renal artery
stenosis. Table II lists mean serum creatinine levels
in all patients before and after repair.
Concomitant blood pressure and function
response
Of all repairs performed for atherosclerosis in
patients with renal insufficiency, 6 of 8 patients
(75%) with an improvement in renal function also
had an improvement in BP. In contrast, 6 of 12
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Table II. Blood pressure and renal function
responses to repair (N = 23 Patients)
ASCD FMD
Before repair
Mean systolic blood pressure* 183.7 ± 8.3 176.7 ± 14.5
Mean diastolic blood pressure† 96.8 ± 5.3 112.7 ± 2.4
Number of medications 2.5 ± 0.25 2.0 ± 0.6
Serum creatinine level 2.7 ± 0.4 0.7 ± 0.03
Number requiring dialysis 3/21 0/2
After repair
Mean systolic blood pressure* 138.4 ± 6.2 125.3 ± 5.3
Mean diastolic blood pressure† 74.1 ± 3.0 75.3 ± 5.3
Number of medications 2.1 ± 0.2 0
Serum creatinine level 2.4 ± 0.4 0.7 ± 0.06
Number requiring dialysis 2/21 0/2
ASCD, atherosclerotic disease; FMD, fibromuscular dysplasia as
etiology of renal artery stenosis.
*Mean (± SE) SBP difference before repair vs. after repair: ASCD,
P = .0003; FMD, P = .041.
†Mean (± SE) DBP difference before repair vs. after repair:
ASCD, P = .007; FMD, P = .012.
patients with an improvement in BP achieved a func-
tional improvement. On the other hand, 3 of 10
patients whose renal function didn’t improve also
had a failed BP response, and 3 of 4 patients who
failed to have an improvement in BP also didn’t have
an improvement in renal function.
For solitary/unilateral repairs performed for ath-
erosclerosis in patients with renal insufficiency, 4 of
6 patients (67%) with an improvement in renal func-
tion also had an improvement in BP, and 4 of 8
patients with an improvement in BP also achieved a
functional improvement. Two of 5 patients (40%)
who didn’t have an improvement in renal function
also had a failed BP response, and 2 of 3 patients
with a BP failure also had a functional failure. Only
1 of 4 patients with a BP failure had a functional
improvement, whereas 5 of 10 patients with a func-
tional failure had an improvement in BP.
Relation to kidney size
The mean length of all kidneys treated in this
study was 10.2 ± 0.2 cm. No kidney treated was less
than 7 cm long. Twenty-five treated kidneys were
greater than or equal to 8 cm long, and the d/s ratio
was greater than or equal to 0.3 in 16 cases (64%).
However, 3 of the 6 kidneys that were less than 8 cm
long also had d/s ratios greater than or equal to 0.3,
and the smaller kidneys in this study were not more
likely to have a d/s ratio less than 0.3 (P = .65). There
was no significant difference in the mean length of
kidneys in patients who experienced an improvement
in BP control after renal revascularization, as com-
pared with those that did not have an improvement in
BP (10.2 ± 0.4 cm vs. 10 ± 0.8 cm, P = .64). Similarly,
there was no significant difference in kidney size in
patients having functional improvement, as compared
with those who did not have functional improvement
(P = .10). Overall, no significant impact of kidney
length alone could be detected in this study.
Postoperative morbidity and mortality
There were no deaths in the patient group dur-
ing the first 30 days of hospitalization; however, 2
patients undergoing operative revascularization for
atherosclerosis died from cardiac events in the hos-
pital more than 30 days after their operations, and 1
patient died at another hospital from heart failure
approximately 40 days after operative revasculariza-
tion for atherosclerosis (total perioperative mortality
of 13%). There were 5 additional late deaths in the
atherosclerosis group, 1 from metastatic recurrence
and 3 from late cardiac events. Two patients from
the atherosclerosis group were identified by means
of renal duplex as having early failures of their
bypasses within 30 days of repair. No deaths
occurred in either patient undergoing repair for
FMD, but 1 patient initially cured of her hyperten-
sion after PTA recurred with severe hypertension 2
years after PTA, despite normal findings on bilateral
renal duplex scans. Branch disease was revealed at a
new site by means of angiography, and she under-
went successful ex vivo repair, with subsequent cure
of her hypertension.
DISCUSSION
Hypertension that is caused by renal artery
stenosis (RAS) can be significantly improved or
cured by surgery or percutaneous transluminal
angioplasty. If untreated, it can lead to deterioration
in renal function, loss of renal mass, and possibly
complete occlusion of the renal artery.24,25 The abil-
ity to predict, noninvasively, which patients will have
a successful outcome to renal revascularization pro-
cedures remains an elusive clinical goal. To date,
functional studies or tests that assess the functional
significance of a renal artery occlusive lesion have
proved to be the most promising. Tests such as renal
vein renin assays and split renal function studies have
proven valuable in confirming renal artery
stenoses.26,27 When the findings of such studies are
positive for RAS, in the clinical setting of severe
hypertension and a critical unilateral renal artery
stenosis, the predictability of a successful interven-
tion is quite high. These studies have little value
however, when severe bilateral disease or disease in
the artery supplying a solitary kidney is present. In
these settings, the decision to operate and the bene-
fit of that intervention remain unpredictable, based
clinically on the severity of hypertension and the
magnitude of associated renal insufficiency. 
RDS has been used throughout the past 20 years
as a screening tool to identify those patients who
would benefit from further invasive study, that is,
arteriography. Continued improvements in probe
design and technology has significantly improved
imaging and Doppler-shift interrogation of deep
abdominal vasculature. Today, RDS has proven its
reliability in the evaluation of patients with main
renal artery disease, as well as in the assessment after
intervention (surgical revascularization or angioplas-
ty).19,20 RDS is able to provide both anatomic and
physiologic information in the same test. Renal
artery stenosis and renal parenchymal abnormalities
could potentially be detected by means of RDS.
Despite the reliability and accuracy of RDS,
attempts have been made to simplify the often
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lengthy procedure by examining the arterial signals
from the renal hilum. Handa and colleagues first
observed that distal to a hemodynamically signifi-
cant stenosis there will be loss of the early systolic
peak (ESP) with a slow rise and blunting of the arte-
rial waveform (Tardus Parvus).28 Martin et al. per-
formed similar studies and found that acceleration
time more than 100 ms had a sensitivity of 93% in
predicting significant main RAS.29 Stavros et al. used
this type of pattern recognition to assess renal hilar
arterial patterns and concluded that qualitative
analysis of segmental artery Doppler waveform and
presence of an early systolic peak is the best ultra-
sonographic indicator of RAS.30 Other investigators,
however, have not found this technique in itself to
be accurate in the diagnosis of main renal artery dis-
ease. Kliewer et al. assessed 118 renal arteries and
were unable to differentiate stenosis greater than or
equal to 50% from stenosis less than 50% using dis-
tal renal artery waveform indices and changes in the
early systolic peak alone, although severe stenosis
(80% to 99%) could be differentiated from non-
hemodynamically significant (<50%) stenosis.31 Our
current view, like that of others,7,28 is that hilar sig-
nals provide adjunctive information, but cannot be
used as a sole determinate in diagnosing main renal
artery disease. Nevertheless, much information can
be gained from duplex ultrasonographic analysis of
the renal parenchyma.
One of the compounding factors that compli-
cates the issues involved in studying patients with
renovascular disease or suspected renovascular dis-
ease is the development of parenchymal vascular dis-
ease (arteriolonephrosclerosis). This small vessel dis-
ease will lead to an increase in resistance to blood
flow. One of the first studies of this issue was con-
ducted by Rittenhouse et al., who in a dog model
noted that as the resistance to flow increased, the
end-diastolic velocity decreased.32 This was further
confirmed by Norris et al., who by injecting gel
microspheres into canine renal arteries were able to
increase the vascular resistance and demonstrate that
the end-diastolic flow and its ratio to peak systolic
flow were reduced when the vascular resistance
increased.33 From an ultrasonic standpoint, it is pos-
sible to quantify the peripheral resistance by relating
the end-diastolic velocity to the peak systolic veloci-
ty (the d/s ratio). This information has been
expanded to the clinical setting by several investiga-
tors, who have found that healthy adults have a d/s
ratio of 0.33 to 0.35.34,35 Moreover, a reduced ratio
has been correlated (in the absence of significant
RAS) with an increase in serum creatinine levels. 
In a group of 32 patients with 35 renal interven-
tions, Frauchiger and colleagues have shown that a
preoperative d/s ratio less than 0.3 correlates with
clinical failure of subsequent treatment.15 They did
not find, however, that a value more than 0.3 pre-
dicted success in all cases. We, in contrast, found
that a preoperative d/s ratio more than 0.3 was sig-
nificantly more likely to result in a success in both
BP and renal function than a value less than 0.3.
Moreover, all patients with an unsuccessful BP
response and 7 of 10 patients who failed to have an
appreciable improvement in renal function had d/s
ratios less than 0.3. This agrees with the University
of Washington’s experience for BP response in a
cohort of mostly percutaneous interventions. 
The findings of our study make 2 interesting
points. First, in spite of indirect evidence of signifi-
cantly more flow to the renal mass after technically
successful interventions (as evidenced by a highly
statistical increase in parenchymal peak systolic
velocity), the d/s ratio before and after repair did
not change in any group with patent repairs postop-
eratively. Despite the small number of patients with
FMD in this study, they were no more or less likely
to undergo a change in parenchymal d/s ratio after
repair than those patients having atherosclerosis as
the etiology of renal disease. The ischemic kidney is
acting as an end organ with fixed resistance, unal-
tered by revascularization. Those kidneys with rela-
tively lower resistance measurements preoperatively
may have a smaller component of nephrosclerosis,
and thus they respond more favorably than those
kidneys with more extensive irreversible intra-
parenchymal disease. 
Second, despite the conventional assumption that
small kidney size correlates with more advanced renal
disease, our results found no association between
kidney length and d/s ratio. Although there were no
kidneys shorter than 7 cm in this study, 3 of 6 kid-
neys less than 8 cm long had d/s ratios greater than
0.3, and 9 of 25 kidneys longer than 8 cm had d/s
ratios less than 0.3; 2 kidneys shorter than 8 cm were
associated with a successful BP or functional
response, and 9 of 11 kidneys longer than 8 cm were
associated with failures in BP or functional response.
This suggests that an asymmetry in kidney size
should prompt preoperative assessment of parenchy-
mal resistance before nephrectomy is considered
empirically, and normal kidney size does not neces-
sarily guarantee a successful intervention. 
Our findings do not suggest that attempts at renal
revascularization in patients with preoperative d/s
ratios less than 0.3 are futile. The absolute d/s ratio of
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0.3 may be somewhat arbitrary. Perhaps an absolute
value below which all procedures are doomed to fail-
ure does exist (for example, less than 0.2), but further
studies are necessary to address this question. These
results do suggest, however, the principal that the
degree of intraparenchymal disease can be character-
ized before surgery, and this characterization may aid
the surgeon in planning an operative intervention that
affords the highest likelihood of success. 
CONCLUSION
The preintervention measurement of d/s veloci-
ty ratios from within the renal parenchyma has
promise as a predictor for the outcome of renal
revascularization procedures. Despite the limitations
of this small retrospective study, our data suggest
that a preoperative d/s ratio less than 0.3 correlates
with clinical failure relative to BP and renal func-
tional responses. Although we do not believe that
duplex sonographic measurement of intrarenal flow
patterns alone is accurate at assessing main renal
artery occlusive disease, the resistive indices may
reflect the magnitude of intraparenchymal disease
and thus provide important prognostic information
for patients undergoing surgical revascularization.
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Dr Kimberley J. Hansen (Winston Salem, NC). Dr
Cohen and his colleagues have addressed an important
issue this morning—the clinical response to renal artery
intervention. With the results of tests of physiologic sig-
nificance or empiric treatment on the basis of the severity
of hypertension and the severity of associated renal artery
lesions, contemporary surgical series report beneficial
blood response in 85% to 90% of patients. But in the case
of excretory renal function, the response to surgical inter-
vention is more or less predictable. This is really a question
of renal function response, not one of hypertension. With
the best clinical circumstances (eg, bilateral or global renal
vascular disease), the combination of severe hypertension,
or rapidly deteriorating renal function, only about 50% to
60% of the patients with ischemic nephrectomy are
improved. On the basis of the sparse natural history data
that are currently available, only those patients with an
immediate increase in renal function appear to have long-
term benefit. Patients with unchanged renal function after
intervention remain at risk for end-stage renal disease and
dialysis dependence. By comparison, those patients who
demonstrate increased renal function enjoy improved dial-
ysis-free survival, which is an association that is highly sig-
nificant and independent after controlling for important
covariates. On this basis, a noninvasive method that could
accurately predict renal function response after renal artery
intervention would have important clinical use.
For the relationship between renal Doppler spectral
analysis from hilar and parenchymal vessels and blood pres-
sure and renal function response after intervention, the
basic premise is that the parenchymal, diastolic, and systolic
ratios represent renal vascular resistance, which in turn
reflects intrinsic renal parenchymal disease that could limit
the clinical response after revascularization. If this premise
is correct, renal duplex scan could be a particularly power-
ful tool both as an accurate screening study for main renal
disease and as a predictor of response intervention.
The questions I have relate to the differences between
the experiences of our center and the data that were
reported. We have examined our renal artery results in
terms of endostolic ratios (EDRs), which are the diastolic
systolic ratios from the main renal arteries rather than
from the parenchymas. And although pre-operative EDRs
varied inversely with baseline serum creatinine, they have
shown no association with either blood pressure or renal
function response in more than 300 patients after renal
artery repair.
My question asks whether you think that these differ-
ences reflect differences inherent to spectral information
obtained from the main renal artery versus the renal
parenchyma or differences in our methods of analysis. We
have used analysis of variance to control for differences
within patients.
In this latter regard, what is the negative predictive
value of your examination, and would you be prepared to
withhold treatment on the basis of this examination alone?
Are only kidneys with significant stenosis considered in
your analysis? Are renal artery occlusions considered? You
refer to normal values for parenchymal ratios, but EDRs
vary significantly with age, with type of renal artery occlu-
sive disease (eg, sclerosis versus fibromuscular dysplasia),
with the severity of hypertension, and with the extent of
extrarenal atherosclerosis.
As you recognize the influences of cut-off points in
the sensitivity, specificity, and predictive values of any test,
do you see signals obtained from the parenchyma showing
similar relationships? And if so, how do you plan to
account for these effects as you prospectively expand on
this preliminary experience?
I enjoyed both the paper and the presentation and appre-
ciate the opportunity to open the discussion. Thank you.
Dr E. Jerry Cohn Jr. Thank you for your insightful
comments. We agree with your thoughts that the preop-
erative prediction of excretory functional response is the
most important variable in any noninvasive test.
To answer your question about the apparent discrep-
ancy between our admittedly small series of parenchymal
resistance measurements and your experience at Bowman
DISCUSSION
JOURNAL OF VASCULAR SURGERY
480 Cohn et al September 1998
of hypertensive patients: The renal artery Doppler technique.
Ultrasound Med Biol 1986;12:945–52.
29. Martin B, Nanra RS, Wlodarczyk J. Renal hilar Doppler
analysis in the detection of renal artery stenosis. J Vasc Tech
1991;15:173–80.
30. Stavros TA, Parker SH, Yakes WF, Chantelois AE, Burke BJ,
Meyers PR, et al. Segmental stenosis of the renal artery:
Pattern recognition of Tardus and Parvus abnormalities with
duplex ultrasonography. Radiology 1992;184:487–92.
31. Kliewer MA, Tupler RH, Carroll BA, Paine SS, Kriegshauser
JS, Hertzberg BS. RAS: Analysis of Doppler waveform para-
meters and tardus-parvus pattern. Radiology 1993;189:
779–87.
32. Rittenhouse EA, Maxiner W, Burr J, Barnes RW. Directional
arterial flow velocity: A sensitive index of changes in periph-
eral vascular resistance. Surgery 1976;79:350–5.
33. Norris CS, Barnes RW. Renal artery flow velocity analysis: A
sensitive measure of experimental and clinical renovascular
resistance. J Surg Res 1984;36:230–6.
34. Norris DS, Pfeiffer JS, Rittgers SE, Barnes RW. Noninvasive
evaluation of renal artery stenosis and renovascular resistance:
Experimental and clinical studies. J Vasc Surg 1984;1:
192–201.
35. Gottileb RH, Luhman K, Oates R. Duplex ultrasound evalu-
ation of normal native kidneys and native kidneys with uri-
nary tract obstruction. J Ultrasound Med 1989;8:609–11.
Submitted Jan 27, 1998; accepted May 19, 1998.
Gray, we did not analyze EDR in our main renal arteries.
We believe that parenchymal wave forms represent the
most sensitive measure of parenchymal resistance and have
concerns that proximal occlusive lesions may impair the
accurate measurement of peak systolic end diastolic veloc-
ities in the main renal artery. An analogy could be drawn
with another high-flow, low-resistance bed. We are all
aware that the presence of intracranial occlusive disease is
typically not apparent on conventional duplex evaluation
of the more proximal internal carotid artery. If then
duplex scanning of the renal parenchymal is a valid
method of measuring parenchymal resistance, and we
believe it is, then this test may be of particular value in dis-
criminating between those patients with renal insufficien-
cy and renal artery stenosis who might benefit from revas-
cularization.
To address your question of withholding treatment
based on d/s ratio, we, by no means, wish to propose that
a rigid cutoff should be made below which the patient
should not be offered therapy. The normal value of 0.3 is
somewhat arbitrary. Dr Strandness and his colleagues have
used this number as a cutoff and have found at least a neg-
ative predictive value with response to blood pressure
alone. However, they did not address functional response.
Perhaps, for this indication, an absolute d/s ratio does not
exist below which revascularization is doomed to fail. In
fact, 2 early graft thromboses in our series both had d/s
ratios before surgery of 0.2 or less. Perhaps, 0.2 is a more
realistic number, but nevertheless, we think that renal
parenchymal duplex scanning may be an important
adjunct to aid us in predicting outcome before surgery
and thus help us guide our therapy.
The renal d/s ratio, as you have pointed out, is known
to increase with age and also in patients with either
reversible or irreversible parenchymal disease. This infor-
mation has been previously documented in patients with
renal transplants. We agree that in patients with fibromus-
cular dysplasia, as the etiology of their renal artery steno-
sis, the d/s ratios are normally higher than their cohorts
with atherosclerosis, because, as we all know, the kidneys
in patients with fibromuscular dysplasia are typically free of
parenchymal disease. We know that they tend to respond
better than their cohortive patients with atherosclerosis.
In terms of patients with more diffuse atherosclerotic
disease, we would contend that their diastolic ratios also
tend to be lower. Once again, as you pointed out, our
experience is preliminary and ongoing work at our institu-
tion should clarify the role of this test in the future.
JOURNAL OF VASCULAR SURGERY
Volume 28, Number 3 Cohn et al 481
Don’t miss a single issue of the journal!  To ensure prompt service when you change your address,
please photocopy and complete the form below. 
Please send your change of address notification at least six weeks before your move to ensure continued ser-
vice.  We regret we cannot guarantee replacement of issues missed due to late notification.
JOURNAL TITLE:
Fill in the title of the journal here.
OLD ADDRESS:
Affix the address label from a recent issue of the journal here.
COPY AND MAIL THIS FORM TO: OR FAX TO: OR PHONE:
Journal Subscription Services 314-432-1158 1-800-453-4351
Mosby, Inc. Outside the U.S., call
11830 Westline Industrial Dr. 314-453-4351
St. Louis, MO  63146-3318
NEW ADDRESS:
Clearly print your new address here.
Name
Address
City/State/ZIP
Send us your new address at least six weeks aheadO N THE
